Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Placental SARS-CoV-2 in a patient with mild COVID-19 disease

View ORCID ProfileAlbert L. Hsu, Minhui Guan, Eric Johannesen, Amanda J. Stephens, Nabila Khaleel, Nikki Kagan, Breanna C. Tuhlei, Xiu-Feng Wan
doi: https://doi.org/10.1101/2020.07.11.20149344
Albert L. Hsu
aReproductive Medicine and Fertility Center, Department of Obstetrics and Gynecology, University of Missouri-Columbia School of Medicine; Columbia, Missouri; USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Albert L. Hsu
  • For correspondence: hsual@health.missouri.edu wanx@missouri.edu
Minhui Guan
bMU Center for Research on Influenza Systems Biology (CRISB), University of Missouri, Columbia, MO, USA
cDepartment of Molecular Microbiology and Immunology, School of Medicine, University of Missouri, Columbia, MO, USA
dBond Life Sciences Center, University of Missouri, Columbia, MO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric Johannesen
eDepartment of Pathology and Anatomical Sciences, University of Missouri-Columbia School of Medicine; Columbia, Missouri; USA
DO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amanda J. Stephens
fDivision of Maternal-Fetal Medicine; Department of Obstetrics and Gynecology; University of Missouri-Columbia School of Medicine; Columbia, Missouri; USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nabila Khaleel
gDivision of General Pediatrics, Department of Child Health; University of Missouri-Columbia School of Medicine; Columbia, Missouri; USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nikki Kagan
hUniversity of Missouri School of Medicine Class of 2021; Columbia, Missouri; USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Breanna C. Tuhlei
iUniversity of Missouri School of Medicine MD/PhD candidate; Columbia, Missouri; USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiu-Feng Wan
bMU Center for Research on Influenza Systems Biology (CRISB), University of Missouri, Columbia, MO, USA
cDepartment of Molecular Microbiology and Immunology, School of Medicine, University of Missouri, Columbia, MO, USA
dBond Life Sciences Center, University of Missouri, Columbia, MO, USA
jDepartment of Electrical Engineering & Computer Science, College of Engineering, University of Missouri, Columbia, MO, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background The full impact of COVID-19 on pregnancy remains uncharacterized. Current literature suggests minimal maternal, fetal, and neonatal morbidity and mortality,1 and COVID-19 manifestations appear similar between pregnant and non-pregnant women.2 We present a case of placental SARS-CoV-2 virus in a woman with an uncomplicated pregnancy and mild COVID-19 disease.

Methods A pregnant woman was evaluated at University of Missouri Women and Children’s Hospital. Institutional review board approval was obtained; information was obtained from medical records. Reverse transcriptase-polymerase chain reaction (RT-PCR) was performed to detect SARS-CoV-2. A gynecological pathologist examined the placenta and performed histolopathology. Sections were formalin-fixed and paraffin-embedded; slides were cut and subjected to hematoxylin-and-eosin or immunohistochemistry (IHC) staining. IHC was performed with specific monoclonal antibodies to detect SARS-CoV-2 antigen or to identify trophoblasts.

Findings A 29 year-old multigravida presented at 40-4/7 weeks for labor induction. With myalgias two days prior, she tested positive for SARS-CoV-2. Her parents were in self-isolation for COVID-19 positivity; husband was asymptomatic and tested negative for COVID-19, but exposed to a workplace (meatpacking facility) outbreak.

Prenatal course was uncomplicated, with no gestational hypertension. She was afebrile and asymptomatic with normal vital signs throughout hospitalization. Her myalgias improved prior to admission. A liveborn male infant was delivered vaginally. Newborn course was uneventful; he was appropriate for gestational age, physical was unremarkable, and he was discharged home at 36 hours. COVID-19 RT-PCR test was negative at 24 hours. At one-week follow-up, newborn was breastfeeding well, with no fevers or respiratory distress.

Overall placental histology is consistent with acute uterine hypoxia (subchorionic laminar necrosis) superimposed on chronic uterine hypoxia (extra-villous trophoblasts and focal chronic villitis). IHC using SARS-CoV-2 nucleocapsid-specific monoclonal antibody demonstrated SARS-CoV-2 antigens throughout the placenta in chorionic villi endothelial cells, and rarely in CK7-expressing trophoblasts. Negative control placenta (November 2019 delivery) and ferret nasal turbinate tissues (not shown) were negative for SARS-CoV-2.

Interpretation In this report, SARS-CoV-2 was found in the placenta, but newborn was COVID-19 negative. Our case shows maternal vascular malperfusion, with no features of fetal vascular malperfusion.

To our knowledge, this is the first report of placental COVID-19 despitemildCOVID-19 disease in pregnancy (with no symptoms of COVID-19 aside from myalgias); specifically, this patient had no fever, cough, or shortness of breath, but only myalgias and sick contacts. Despite her having mild COVID-19 disease in pregnancy, we demonstrate placental vasculopathy and presence of SARS-CoV-2 virus across the placenta. Evidence of placental COVID-19 raises concern for possible placental vasculopathy (potentially leading to fetal growth restriction, pre-eclampsia, and other pregnancy complications) as well as for potential vertical transmission – especially for pregnant women who may be exposed to COVID-19 in early pregnancy. Further studies are urgently needed, to determine whether women with mild, pre-symptomatic, or asymptomatic COVID-19 may have SARS-CoV-2 virus that can cross the placenta, cause fetal vascular malperfusion, and possibly affect the fetus. This raises important public health and public policy questions of whether future pregnancy guidance should include stricter pandemic precautions, such as screening for a wider array of COVID-19 symptoms, increased antenatal surveillance, and possibly routine COVID-19 testing on a regular basis throughout pregnancy.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

this research was supported by departmental funding by the Department of Obstetrics and Gynecology at the University of Missouri (Columbia, MO)

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

University of Missouri (MU) Institutional Review Board, project #2025692, acknowledged 06/29/20

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Conflicts of interest: none

  • Financial support: supported by the Department of Obstetrics and Gynecology, University of Missouri School of Medicine

Data Availability

Data referred to in the manuscript is shown in tables and figures.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted July 14, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Placental SARS-CoV-2 in a patient with mild COVID-19 disease
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Placental SARS-CoV-2 in a patient with mild COVID-19 disease
Albert L. Hsu, Minhui Guan, Eric Johannesen, Amanda J. Stephens, Nabila Khaleel, Nikki Kagan, Breanna C. Tuhlei, Xiu-Feng Wan
medRxiv 2020.07.11.20149344; doi: https://doi.org/10.1101/2020.07.11.20149344
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Placental SARS-CoV-2 in a patient with mild COVID-19 disease
Albert L. Hsu, Minhui Guan, Eric Johannesen, Amanda J. Stephens, Nabila Khaleel, Nikki Kagan, Breanna C. Tuhlei, Xiu-Feng Wan
medRxiv 2020.07.11.20149344; doi: https://doi.org/10.1101/2020.07.11.20149344

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Obstetrics and Gynecology
Subject Areas
All Articles
  • Addiction Medicine (269)
  • Allergy and Immunology (549)
  • Anesthesia (135)
  • Cardiovascular Medicine (1749)
  • Dentistry and Oral Medicine (238)
  • Dermatology (172)
  • Emergency Medicine (310)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (654)
  • Epidemiology (10785)
  • Forensic Medicine (8)
  • Gastroenterology (584)
  • Genetic and Genomic Medicine (2935)
  • Geriatric Medicine (286)
  • Health Economics (531)
  • Health Informatics (1919)
  • Health Policy (833)
  • Health Systems and Quality Improvement (743)
  • Hematology (290)
  • HIV/AIDS (627)
  • Infectious Diseases (except HIV/AIDS) (12501)
  • Intensive Care and Critical Care Medicine (685)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (323)
  • Neurology (2786)
  • Nursing (150)
  • Nutrition (431)
  • Obstetrics and Gynecology (556)
  • Occupational and Environmental Health (597)
  • Oncology (1458)
  • Ophthalmology (441)
  • Orthopedics (172)
  • Otolaryngology (255)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (380)
  • Pediatrics (865)
  • Pharmacology and Therapeutics (362)
  • Primary Care Research (334)
  • Psychiatry and Clinical Psychology (2633)
  • Public and Global Health (5342)
  • Radiology and Imaging (1004)
  • Rehabilitation Medicine and Physical Therapy (595)
  • Respiratory Medicine (724)
  • Rheumatology (329)
  • Sexual and Reproductive Health (289)
  • Sports Medicine (278)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (149)
  • Urology (125)